Showing 24 out of 106 results
A ‘new normal’ when it comes to the TGA regulation of medical devices?
Key points: In Australia responding to the urgent need for Covid-related medical devices the TGA implemented a number of emergency measures to bring …
Asia Pacific M&A Review 2021
Our eighth annual review of Asia's deal scene assesses the outlook for big-ticket M&A after a turbulent but eventful yearChange is the only constant …
2020 Australian IPO Review: IPOs by the numbers
A challenging year Market conditions in 2020 unfolded like an obstacle course and were significantly impacted by the onset of the Covid-19 pandemic, …
2020 Australian IPO Review: Key themes
2020 in review Market conditions in 2020 were of course impacted by the Covid-19 pandemic, but also by record low interest …
Australian IPOs defy early expectations to achieve record end to 2020
The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
Healthcare as an Infrastructure asset
The search for yield is driving infrastructure investors to expand beyond typical core infrastructure assets into core+ or ‘infra-like’ assets. As part …
The arrival of the Omnibus
Fair Work Act changes for the COVID recovery Following a gestation of seven months, the Workplace Relations Reform: Fair Work Amendment (Supporting …
Deciphering the complex world of underpayment of wages: compliance and enforcement
There have been a number of recent examples of large Australian corporates disclosing that members of their workforce have been underpaid, demonstrating …
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
Herbert Smith Freehills advises Rosemary Health on Series Seed capital raise
Herbert Smith Freehills’ venture capital team has advised Rosemary Health on its Series Seed capital raise.Rosemary Health is telehealth platform that …
The Carry: Private Equity Insights
Herbert Smith Freehills is pleased to announce the second edition of The Carry: Private Equity Insights. In this edition we cover: Key themes …
Digihealth and the dash for data – The key legal issues
As Big Pharma meets Big Tech, demand for health data has exploded. We steer you through the rocky ethical and regulatory terrainThe healthcare and …
Showing 24 out of 106 results
View more